종양학 정보 시스템 시장 규모, 점유율 및 동향 분석 보고서 : 제품·서비스별, 용도별, 최종 용도별, 지역별 및 부문별 예측(2026-2033년)

Oncology Information Systems Market Summary

The global oncology information systems market size was estimated at USD 3.2 billion in 2025 and is projected to reach USD 6.0 billion by 2033, growing at a CAGR of 8.3% from 2026 to 2033. The increasing burden of cancer cases and the growing need for precision oncology drive the adoption of oncology information systems (OIS).

In addition, the shift toward artificial intelligence (AI)-driven treatment planning and real-time patient monitoring is transforming oncological workflows by enhancing accuracy and efficiency.

Market Drivers & Dynamics

Increasing Prevalence of Cancer

The rising global burden of cancer is a key market growth driver. According to the WHO, cancer remains a leading cause of mortality globally, accounting for approximately one in every six deaths. In addition, the Global Cancer Statistics 2022 reported 19.96 million new cancer cases and 9.73 million deaths, with lung, colorectal, liver, and breast cancers contributing to the highest mortality rates. The growing number of cancer cases demands efficient patient data management, treatment planning, and precision oncology solutions, further fueling the adoption of OIS.

Global Oncology Information Systems Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global oncology information systems market report based on products & services, application, end use, and region:

• Products & Services Outlook (Revenue, USD Million, 2021 - 2033)
• Solutions
  • Patient Information Systems
  • Treatment Planning Systems
• Professional Services
• Application Outlook (Revenue, USD Million, 2021 - 2033)
• Medical Oncology
• Radiation Oncology
• Surgical Oncology
• End Use Outlook (Revenue, USD Million, 2021 - 2033)
• Hospitals and Diagnostic Imaging Centers
• Ablation Care Centers and Cancer Care Centers
• Government Institutions
• Research Facilities
• Regional Outlook (Revenue, USD Million, 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Thailand
• Latin America
  • Brazil
  • Argentina
• Middle East and Africa (MEA)
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Products & Services
  • 1.2.2. Application
  • 1.2.3. End Use
• 1.3. Estimates and Forecast Timeline
• 1.4. Research Methodology
• 1.5. Information Procurement
  • 1.5.1. Purchased Database
  • 1.5.2. GVR's Internal Database
  • 1.5.3. Secondary Sources
  • 1.5.4. Primary Research
• 1.6. Information Analysis
  • 1.6.1. Data Analysis Models
• 1.7. Market Formulation & Data Visualization
• 1.8. Model Details
  • 1.8.1. Commodity Flow Analysis
• 1.9. List of Secondary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Snapshot
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Increasing prevalence of cancer
    • 3.2.1.2. Increasing investments and strategic initiatives in radiology and oncology
    • 3.2.1.3. Technological advancements
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. Cybersecurity and privacy concerns
    • 3.2.2.2. Shortage of healthcare personnel in information technology
  • 3.2.3. Industry Challenge Analysis
  • 3.2.4. Case Studies
• 3.3. Business Environment Analysis
  • 3.3.1. Porter's Five Forces Analysis
    • 3.3.1.1. Supplier power
    • 3.3.1.2. Buyer power
    • 3.3.1.3. Substitution threat
    • 3.3.1.4. Threat of new entrant
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTLE Analysis

Chapter 4. Oncology Information Systems Market: Products & Services Estimates & Trend Analysis

. Products & Services Segment Dashboard

• 4.2. Products & Services Market Share Movement Analysis, 2025 & 2033
• 4.3. Market Size & Forecasts and Trend Analysis, by Products & Services, 2021 to 2033 (USD Million)
• 4.4. Solutions
  • 4.4.1. Solutions market, 2021 - 2033 (USD Million)
  • 4.4.2. Patient Information Systems
    • 4.4.2.1. Patient information systems market, 2021 - 2033 (USD Million)
  • 4.4.3. Treatment Planning Systems
    • 4.4.3.1. Treatment planning systems market, 2021 - 2033 (USD Million)
• 4.5. Professional Services
  • 4.5.1. Professional Services market, 2021 - 2033 (USD Million)

Chapter 5. Oncology Information Systems Market: Application Estimates & Trend Analysis

• 5.1. Application Segment Dashboard
• 5.2. Application Market Share Movement Analysis, 2025 & 2033
• 5.3. Market Size & Forecasts and Trend Analysis, by Application, 2021 to 2033 (USD Million)
• 5.4. Medical Oncology
  • 5.4.1. Medical oncology market, 2021 - 2033 (USD Million)
• 5.5. Radiation Oncology
  • 5.5.1. Radiation oncology market, 2021 - 2033 (USD Million)
• 5.6. Surgical Oncology
  • 5.6.1. Surgical oncology market, 2021 - 2033 (USD Million)

Chapter 6. Oncology Information Systems Market: End Use Estimates & Trend Analysis

• 6.1. End Use Segment Dashboard
• 6.2. End Use Market Share Movement Analysis, 2025 & 2033
• 6.3. Market Size & Forecasts and Trend Analysis, by End Use, 2021 to 2033 (USD Million)
• 6.4. Hospitals & Diagnostic Imaging Centers
  • 6.4.1. Hospitals & diagnostic imaging centers market, 2021 - 2033 (USD Million)
• 6.5. Ablation Care Centers & Cancer Care Centers
  • 6.5.1. Ablation care centers and cancer care centers market, 2021 - 2033 (USD Million)
• 6.6. Government Institutions
  • 6.6.1. Government institutions market, 2021 - 2033 (USD Million)
• 6.7. Research Facilities
  • 6.7.1. Research facilities market, 2021 - 2033 (USD Million)

Chapter 7. Oncology Information Systems Market: Regional Estimates & Trend Analysis

• 7.1. Regional Market Dashboard
• 7.2. Regional Market: Key Takeaways
• 7.3. North America
  • 7.3.1. North America oncology information systems market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.3.2. U.S.
    • 7.3.2.1. Key country dynamic
    • 7.3.2.2. Regulatory framework
    • 7.3.2.3. Competitive insights
    • 7.3.2.4. U.S. oncology information systems market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.3.3. Canada
    • 7.3.3.1. Key country dynamic
    • 7.3.3.2. Regulatory framework
    • 7.3.3.3. Competitive insights
    • 7.3.3.4. Canada oncology information systems market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.3.4. Mexico
    • 7.3.4.1. Key country dynamic
    • 7.3.4.2. Regulatory framework
    • 7.3.4.3. Competitive insights
    • 7.3.4.4. Mexico oncology information systems market estimates and forecasts, 2021 - 2033 (USD Million)
• 7.4. Europe
  • 7.4.1. Europe oncology information systems market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.4.2. Germany
    • 7.4.2.1. Key country dynamic
    • 7.4.2.2. Regulatory framework
    • 7.4.2.3. Competitive insights
    • 7.4.2.4. Germany oncology information systems market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.4.3. UK
    • 7.4.3.1. Key country dynamic
    • 7.4.3.2. Regulatory framework
    • 7.4.3.3. Competitive insights
    • 7.4.3.4. UK oncology information systems market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.4.4. France
    • 7.4.4.1. Key country dynamic
    • 7.4.4.2. Regulatory framework
    • 7.4.4.3. Competitive insights
    • 7.4.4.4. France oncology information systems market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.4.5. Italy
    • 7.4.5.1. Key country dynamic
    • 7.4.5.2. Regulatory framework
    • 7.4.5.3. Competitive insights
    • 7.4.5.4. Italy oncology information systems market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.4.6. Spain
    • 7.4.6.1. Key country dynamic
    • 7.4.6.2. Regulatory framework
    • 7.4.6.3. Competitive insights
    • 7.4.6.4. Spain oncology information systems market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.4.7. Denmark
    • 7.4.7.1. Key country dynamic
    • 7.4.7.2. Regulatory framework
    • 7.4.7.3. Competitive insights
    • 7.4.7.4. Denmark oncology information systems market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.4.8. Sweden
    • 7.4.8.1. Key country dynamic
    • 7.4.8.2. Regulatory framework
    • 7.4.8.3. Competitive insights
    • 7.4.8.4. Sweden oncology information systems market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.4.9. Norway
    • 7.4.9.1. Key country dynamic
    • 7.4.9.2. Regulatory framework
    • 7.4.9.3. Competitive insights
    • 7.4.9.4. Norway oncology information systems market estimates and forecasts, 2021 - 2033 (USD Million)
• 7.5. Asia Pacific
  • 7.5.1. Asia Pacific oncology information systems market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.5.2. Japan
    • 7.5.2.1. Key country dynamic
    • 7.5.2.2. Regulatory framework
    • 7.5.2.3. Competitive insights
    • 7.5.2.4. Japan oncology information systems market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.5.3. China
    • 7.5.3.1. Key country dynamic
    • 7.5.3.2. Regulatory framework
    • 7.5.3.3. Competitive insights
    • 7.5.3.4. China oncology information systems market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.5.4. India
    • 7.5.4.1. Key country dynamic
    • 7.5.4.2. Regulatory framework
    • 7.5.4.3. Competitive insights
    • 7.5.4.4. India oncology information systems market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.5.5. South Korea
    • 7.5.5.1. Key country dynamic
    • 7.5.5.2. Regulatory framework
    • 7.5.5.3. Competitive insights
    • 7.5.5.4. South Korea oncology information systems market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.5.6. Australia
    • 7.5.6.1. Key country dynamic
    • 7.5.6.2. Regulatory framework
    • 7.5.6.3. Competitive insights
    • 7.5.6.4. Australia oncology information systems market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.5.7. Thailand
    • 7.5.7.1. Key country dynamic
    • 7.5.7.2. Regulatory framework
    • 7.5.7.3. Competitive insights
    • 7.5.7.4. Thailand oncology information systems market estimates and forecasts, 2021 - 2033 (USD Million)
• 7.6. Latin America
  • 7.6.1. Latin America Oncology Information Systems Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.6.2. Brazil
    • 7.6.2.1. Key country dynamic
    • 7.6.2.2. Regulatory framework
    • 7.6.2.3. Competitive insights
    • 7.6.2.4. Brazil oncology information systems market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.6.3. Argentina
    • 7.6.3.1. Key country dynamic
    • 7.6.3.2. Regulatory framework
    • 7.6.3.3. Competitive insights
    • 7.6.3.4. Argentina oncology information systems market estimates and forecasts, 2021 - 2033 (USD Million)
• 7.7. MEA
  • 7.7.1. MEA oncology information systems market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.7.2. South Africa
    • 7.7.2.1. Key country dynamic
    • 7.7.2.2. Regulatory framework
    • 7.7.2.3. Competitive insights
    • 7.7.2.4. South Africa oncology information systems market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.7.3. Saudi Arabia
    • 7.7.3.1. Key country dynamic
    • 7.7.3.2. Regulatory framework
    • 7.7.3.3. Competitive insights
    • 7.7.3.4. Saudi Arabia oncology information systems market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.7.4. UAE
    • 7.7.4.1. Key country dynamic
    • 7.7.4.2. Regulatory framework
    • 7.7.4.3. Competitive insights
    • 7.7.4.4. UAE oncology information systems market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.7.5. Kuwait
    • 7.7.5.1. Key country dynamic
    • 7.7.5.2. Regulatory framework
    • 7.7.5.3. Competitive insights
    • 7.7.5.4. Kuwait oncology information systems market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Participant Overview
• 8.2. Company Market Position Analysis
• 8.3. Company Categorization
• 8.4. Strategy Mapping
• 8.5. Company Profiles/Listing
  • 8.5.1. Accuray Incorporated
    • 8.5.1.1. Overview
    • 8.5.1.2. Financial performance
    • 8.5.1.3. Products & Services benchmarking
    • 8.5.1.4. Strategic initiatives
  • 8.5.2. Elekta
    • 8.5.2.1. Overview
    • 8.5.2.2. Financial performance
    • 8.5.2.3. Products & Services benchmarking
    • 8.5.2.4. Strategic initiatives
  • 8.5.3. Prowess, Inc.
    • 8.5.3.1. Overview
    • 8.5.3.2. Financial performance
    • 8.5.3.3. Products & Services benchmarking
    • 8.5.3.4. Strategic initiatives
  • 8.5.4. BrainLab
    • 8.5.4.1. Overview
    • 8.5.4.2. Financial performance
    • 8.5.4.3. Products & Services benchmarking
    • 8.5.4.4. Strategic initiatives
  • 8.5.5. DOSIsoft SA
    • 8.5.5.1. Overview
    • 8.5.5.2. Financial performance
    • 8.5.5.3. Products & Services benchmarking
    • 8.5.5.4. Strategic initiatives
  • 8.5.6. FLATIRON HEALTH
    • 8.5.6.1. Overview
    • 8.5.6.2. Financial performance
    • 8.5.6.3. Products & Services benchmarking
    • 8.5.6.4. Strategic initiatives
  • 8.5.7. RaySearch Laboratories
    • 8.5.7.1. Overview
    • 8.5.7.2. Financial performance
    • 8.5.7.3. Products & Services benchmarking
    • 8.5.7.4. Strategic initiatives
  • 8.5.8. Oracle (Cerner Corporation)
    • 8.5.8.1. Overview
    • 8.5.8.2. Financial performance
    • 8.5.8.3. Products & Services benchmarking
    • 8.5.8.4. Strategic initiatives
  • 8.5.9. Koninklijke Philips N.V.
    • 8.5.9.1. Overview
    • 8.5.9.2. Financial performance
    • 8.5.9.3. Products & Services benchmarking
    • 8.5.9.4. Strategic initiatives
  • 8.5.10. Varian Medical Systems, Inc. (Siemens Healthineers)
    • 8.5.10.1. Overview
    • 8.5.10.2. Financial performance
    • 8.5.10.3. Products & Services benchmarking